Intraurineadhesions after endometrial ablation
Conditions
Interventions
Intrauterine instillation of MateRegen gel after NovaSure treatment.
Sponsors
none
Eligibility
Inclusion criteria
Inclusion criteria: • Women suffering symptoms from HMB, scheduled for a NovaSure endometrial ablation • Women in pre-menopausal age
Exclusion criteria
Exclusion criteria: • Women younger than 34 • Women with a desire to preserve fertility • Women with intracavitary pathology or big intramural myoma seen by transvaginal ultrasound. • Women with a history of a previous endometrial ablation or curettage • Women with cervix pathology
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| We will investigate the prevalence and describe the severity of IUAs (using a valid scoring system, the American Fertility Society (AFS) classification system) following NovaSure treatment for HMB with NCH gel compared to a NovaSure treatment without the NCH gel. In order to prepare for a future hypothesis testing randomized trial. | — |
Secondary
| Measure | Time frame |
|---|---|
| We will also investigate the complications (like uterus perforation and infection) that can occur during administration of the NCH gel in the uterus. Also, we will investigate dysmenorrhoea/ abdominal pain, PBAC score and menstrual bleeding pattern and patient’s satisfaction between the group of patients following NovaSure treatment with NCH and without the NCH gel. | — |
Contacts
Public ContactElke Thijs
Maxima Medisch Centrum
Outcome results
None listed